Nigeria Dialysis Market Analysis Sample Report

Nigeria Dialysis
Market
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of the Nigeria Dialysis Market
and a forecast for its development in the medium and long term. It provides
a comprehensive overview of the market value, dynamics, segmentation,
main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Nigeria Dialysis
Market, and offers unmatched value, accuracy, and expert insights

3
A Sample Report on Nigeria Dialysis Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Nigeria Dialysis Overview 13-23
1.1. Overview
1.2. Nigeria Overview
1.3. Economic Overview: Nigeria
1.4. Dialysis Market in Nigeria
1.5. Healthcare Service Market in Nigeria
1.6. Healthcare Scenario in Nigeria
1.7. Health Insurance Coverage: Nigeria
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 24-29
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Product Type
2.2.2. By Application
2.2.3. By End Use
3. Market Dynamics 30-34
3.1. Market Growth Drivers
3.1.1. Growing Burden of Chronic Kidney Disease (CKD)
3.1.2. Increasing prevalence of Hypertension and Diabetes
3.1.3. Increasing Public Private Partnership
3.2. Market Restraints
3.2.1. Affordability and Financial Constraints
3.2.2. Lack of Skilled Healthcare Professionals

6
Table of Content
CONTENT PG. NO.
3.2.3. Limited Awareness and Education
4. Competitive Landscape 35-44
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Fresenius Medical Care AG & Co. KGaA
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. JNC International
4.2.2.1. Overview

7
Table of Content
CONTENT PG. NO.
4.2.3. Braun Melsungen AG
4.2.3.1. Overview
4.2.4. DaVita Inc
4.2.4.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.5. Baxter International Inc.
4.2.5.1. Overview
4.2.6. NephroCare Nigeria
4.2.6.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.7. Nipro Corporation
4.2.7.1. Overview
4.2.8. Kidney Clinics Nigeria
4.2.8.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.9. Lagoon Hospitals Renal Dialysis Center
4.2.9.1. Overview
4.2.10. Kidney Clinics Nigeria Limited
4.2.10.1. Overview

11
Table of Content
CONTENT PG. NO.
5. Reimbursement Scenario - Nigeria 45-48
5.1 Reimbursement Regulation by Nigerian Government
5.2 Reimbursement process for dialysis treatment in Nigeria
6. Methodology & Scope 49-54

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

Nigeria Dialysis Market Analysis
1. Nigeria Dialysis Market Overview

14
1.1 Nigeria Overview
213.4 Mn
Is the total
population of Nigeria
(2021)
18.1 years
Is the median age
in Nigeria (2021)
$504 Bn
Is the total Gross
domestic product
(GDP) of Nigeria
(2022)
$2,326
GDP per capita
of Nigeria (2022)
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest

15
1.2 Economic Overview: Nigeria
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Nigeria, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Nigeria, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

16
1.3 Statistics at a Glance: The Chronic Kidney Diseases (CKD) in Nigeria
CKD Epidemiology in Nigeria
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Nigeria
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
18%
Is the prevalence of
CKD of in a rural
community in
South-Western
Nigeria
11.4%
CKD in rural area of
South-East Nigeria
12%
Is the overall
prevalence of CKD in
Nigeria
26%
CKD in North-West
Nigeria
14.1% and 9.5%
CKD in women and
men respectively in
Nigeria
11.7%
CKD in semi-urban
dwellers of South-
East Nigeria

17
1.3 Statistics at a Glance: The Chronic Kidney Diseases (CKD) in Nigeria
(continued)
Current status of CKD and its service in Nigeria
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Nigeria
▪ 20 Mn Nigerians are living with CKD
▪ 1% (200,000) of people living with CKD population are likely to progress to ESKD
▪ 2% (3000) of Nigerian ESKD patients were receiving hemodialysis in 2018; this
situation has not changed much in 2022
▪ There are only 240 nephrologists, 697 registered dialysis nurses (145 of these
migrated to Western countries), and 120 dialysis technologists/technicians
delivering care to the large population of CKD patients in Nigeria
Cost of Dialysis in Nigeria:
▪ The financial cost of hemodialysis is still prohibitive for most Nigerians, considering
the minimum wage of $72
▪ average cost of a session of hemodialysis is $96 compared with US$150 about 10
years ago; and the cost is usually higher in private facilities
▪ A tunnel catheter costs $192, temporary central catheter $60, and a femoral catheter
$24, and AVF surgery costs $316–$722

18
1.4 Healthcare Services in Nigeria
XX XX XX XX XX XX XX XX XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Nigeria Healthcare Services Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall healthcare services market in Nigeria, which includes the market size, current
trends and other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
▪ National Health Insurance Scheme (NHIS): A government implemented program aimed at providing affordable and accessible
healthcare services to Nigerians, which helps to reduce out-of-pocket payments for healthcare and promotes financial risk protection
▪ Revitalization of Primary Healthcare Centers (PHCs): Nigerian government embarked on a program to revitalize PHCs across the
country. This initiative includes improving infrastructure, staffing, and the availability of essential drugs at the primary healthcare level,
which is crucial for delivering basic healthcare services to communities
▪ Disease Control Programs: Government has prioritized disease control programs to combat major public health issues. Programs
targeting diseases like malaria, HIV/AIDS, tuberculosis, and vaccine-preventable diseases have been implemented, leading to
improvements in disease management and prevention
▪ National Agency for Food and Drug Administration and Control (NAFDAC): NAFDAC is to regulate and control the manufacture,
importation, exportation, distribution, advertisement, and use of food, drugs, cosmetics, medical devices, and chemicals. NAFDAC plays
a crucial role in ensuring the safety, quality, and efficacy of healthcare products in Nigeria.
May 2022
▪ The Nigerian government signed into law the new National Health Insurance Act (NHIA) 2022
▪ NHIA replaces the National Health Insurance Scheme Act of 1999, which failed to enroll more than 10% of the
population
▪ NHIA seeks to promote, regulate and integrate health insurance schemes
▪ It aims to secure mandatory health insurance for every Nigerian and legal resident, and establishes a fund for the
vulnerable groups, which will provide ‘subsidy for health insurance coverage for vulnerable persons and payment
of health insurance premiums for indigents
A few recent developments related to hemodialysis and peritoneal dialysis are mentioned below
1.5 Healthcare Scenario in Nigeria

20
1.5 Healthcare Scenario: Patient journey with Dialysis
Nephrologist
▪ Prevention and
management of CKD
▪ Delay and prepare for
dialysis
Early Care and
Prevention
Primary care Clinician
referral
Transition into Dialysis
Hospitalization
Vascular access
or peritoneal
Dialysis catheter
placement
Dialysis Facility
• Education
• Modality Selection
• Insurance Initiation
facility
selection
unplanned
entry
Ongoing care coordination
In-Center Dialysis
modality
switch
Home Dialysis
• Peritoneal Dialysis
• Hemodialysis
acute care
episode
acute care
episode
Transplant
center
assessment
for transplant
Hospital
ongoing transplant management and care
planned
entry
failed
transplant

21
1.6 Health Insurance Coverage: Nigeria
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

22
A Sample Report on Africa Dialysis Market Analysis I Confidential
1.8 Budget of Africa Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

23
A Sample Report on Africa Dialysis Market Analysis I Confidential
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

2. Market Size and Forecasting

25
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Nigeria Dialysis Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
and other details related to the topic
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Nigeria Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Nigeria Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative

26
2.2 Snapshot of Dialysis Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Nigeria Dialysis Market
By Product Type By Application By End Use
Hemodialysis (HD)
Equipment
Peritoneal Dialysis
(PD) Equipment
Concentrates and
Solutions
Catheters and
Tubings
Other Products
Hemodialysis
Contract Research
Organizations
(CROs) Peritoneal
Dialysis
In-Center Dialysis
Settings
Home Care Settings

27
Nigeria Dialysis Market Share, By Product Type (2022)
Hemodialysis
(HD) Equipment
Peritoneal
Dialysis (PD)
Equipment
Concentrates
and Solutions
Catheters and
Tubings
Other Products
▪ Hemodialysis market in Nigeria is a
significant component of the overall
dialysis treatment market
final report
2.2.1 Market Segmentation: By Product Type
Illustrative

28
Nigeria Dialysis Market Share, By Application Type (2022)
Hemodialysis
Contract
Research
Organizations
(CROs)
Peritoneal
Dialysis
2.2.2 Market Segmentation: By Application Type
▪ Hemolialysis market in Nigeria is a
significant component of the overall
cancer market
final report
Illustrative

29
Nigeria Dialysis Market Share, By End User (2022)
In-Center
Dialysis Settings
Home Care
Settings
2.2.3 Market Segmentation: By End User
▪ In-center dialysis settings have the
maximum market share in Nigeria
dialysis market with approximately xx%
final report
Illustrative

3. Market Dynamics

31
3.1 Market growth drivers
▪ There is insufficient population-based data on CKD in Nigeria that is
required to estimate its true burden, and to design prevention and
management strategies
▪ End-stage renal disease (ESRD) accounts for 8% of all medical
admissions and 42% of renal admissions in Nigeria
▪ The prevalence of CKD in respondents 60 years and above was 27.8% in
rural, 32.9% in semiurban and 30.4% in both communities combined
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 In Nigeria crude prevalence of CKD was 14.7%, in the semiurban and rural populations the prevalence is 13.6%
and 16.9% respectively
Chronic Kidney Disease Burden in Nigeria

32
3.1 Market growth drivers (continued)
Emergence of diabetes mellitus as an increasingly common cause has been documented in a study where diabetes
mellitus constituted 28.4% of CKD cases
▪ Hypertension is a major cause of CKD and chronic renal failure (CRF) in
Nigeria, in Enugu (South East) and Benin City (South South),
hypertension is the commonest cause of CKD and CRF
▪ It is only second to chronic glomerulonephritis in the South West, virtually
all these reports are from urban settings
▪ Factors such as hypertension, diabetes, and lifestyle changes contribute
to the increasing incidence of kidney diseases, creating a higher demand
for dialysis services
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be presented
in the final report
▪ In order to obtain access to all of the information that you are seeking, you
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest 2010 2022 2030
Prevalence of Hypertension and Diabetes in
Nigeria

33
3.1 Market growth drivers (continued)
3.1.3 Despite its shortcomings, these data showed that Public Private Partnership (PPP) run renal center is reliable
in terms of regular access to service delivery when compared to some government-operated hospitals
▪ Public-Private Partnerships: Collaboration between public and private entities in the healthcare sector drives the dialysis market
▪ Public-private partnerships enable the development of dialysis centers, procurement of equipment and supplies, capacity building,
and the provision of affordable dialysis services to a larger population
▪ PPP has improved the availability of dialysis service, mean duration on dialysis, and mean number of dialysis sessions but did not
improve the kidney transplant referral rate
▪ This is because it is free of the bureaucracy that characterizes public sector management with issues related to maintenance and
supplies
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that
will be presented in the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest

34
3.2 Market restraints
3.2.1 Affordability is a
significant restraint in
the Nigeria dialysis
market
▪ Financial cost of hemodialysis is still
prohibitive for most Nigerians,
considering the minimum wage of
US$72
▪ Average cost of a session of
hemodialysis is US$96 compared
with US$150 about 10 years ago;
and the cost is usually higher in
private facilities
▪ Out-of-pocket payment is an
enormous barrier to equitable
dialysis access, which will hamper
the Nigeria dialysis market
3.2.2 Lack of political
interference for kidney
disease pretension and
treatment
▪ Government lacks the political will
regarding improved care for ESKD
patients, and this is despite
advocacy efforts of nephrology
associations and other
nongovernmental organizations
▪ Unfortunately, accurate data on the
burden of ESKD in Nigeria are still
lacking, and this crucial information
is needed for more effective
advocacy which will further
restraining the dialysis market across
the country
3.2.3 Lack of awareness about
kidney diseases, and available
treatment options restraining the
Nigeria dialysis market
▪ Awareness level of the Nigerian on
kidney functions and diseases was
poor
▪ 60% of the Nigerian had a poor
knowledge of kidney functions and
disease
▪ Insufficient education and
awareness campaigns among the
general population, healthcare
professionals, and policymakers can
result in delayed diagnoses, late
referrals to dialysis centers, and
underutilization of dialysis services
Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth.

4. Competitive Landscape

36
4.1 Major Market Share
▪ Nigeria dialysis market is a highly
competitive space, with many companies
developing and marketing cancer
treatments
▪ Some of the top companies in Nigeria
dialysis market based on revenue and
market share include
interest
Revenue of Major players in Nigeria Dialysis Market ($ Mn)
XX
Company10
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9

37
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Fresenius Medical Care AG &
Co. KGaA
3 Braun Melsungen AG
5 Baxter International Inc.
7 Nipro Corporation
9 Lagoon Hospitals Renal
Dialysis Center
2 JNC International
4 DaVita Inc
6 NephroCare Nigeria
8 Kidney Clinics Nigeria
Kidney Clinics Nigeria
Limited
10
Key Note:

38
4.2.1 JNC International
Founded in: 1992
HQ: Lagos, Nigeria
Type: Private
Revenue: $XX Bn (2022)
Website: www.jnciltd.com
▪ JNC International are a leading Turnkey Medical Equipment
Services and Solutions Company in Nigeria
▪ JNC International focuses on distributing and supplying medical
equipment, including dialysis machines, consumables, and related
supplies, to healthcare institutions and providers in Nigeria
▪ They work with hospitals, clinics, and other healthcare facilities to
ensure the availability of quality dialysis equipment and products
▪ It’ expertise lies in sourcing and delivering advanced medical
technologies from reputable global manufacturers
Company at Glance
➢ Medical Equipment Distribution
➢ Equpment Installation and Training
➢ Equipment Maintenance and
Support
➢ Equipment Maintenance and
Support:
➢ Healthcare IT Solutions
➢ Training and Capacity Building
JNC International Clients
Lagos University Teaching
Hospital, Lagos
Afe Babalola University
Teaching Hospital
Aminu Kano University
Teaching Hospital
Ahmadu Bello University
Teaching Hospital
National Orthopaedic
Hospitals
Euracare Multi-Specialist
Hospital
Reddington Hospital Zaria - ABUTH Lagoon Hospitals
Federal Medical Centres Ibom Specialist Hospital
Babcock University
Teaching Hospital
Renal Pharmaceuticals Renal Consulting Services National Hospital
Recent News/ Press Release
▪ November 2022, JNCI Equips Kelina Hospitals,
Lagos, Kelina Hospitals officially opened its Lagos
branch
▪ April 2022, Evidence supports Public Private
Partnerships (PPP) as a strategy to improving
healthcare infrastructure and operations
▪ PPPs involve long term collaboration between the
public institutions and private sector participants
and are characterized by the sharing of risks,
responsibilities and rewards between partners

39
4.2.1 JNC International (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Ivenix, Inc. acquired by
Fresenius Kabi
Acquisition $240 Mn
March
2022
▪ Ivenix, Inc. announced that it has entered into a definitive
agreement to be acquired by Fresenius Kabi, a global health care
leader specializing in lifesaving medicines and technologies for
infusion, transfusion and clinical nutrition
▪ Ivenix’s advanced infusion system combined with Fresenius Kabi’s
intravenous fluids and infusion therapy offerings will bring a
comprehensive portfolio of infusion products to US
▪ Purchase price will be a combination of $240 Mn upfront payment
and milestone payments linked to achievements of commercial and
operating targets
ExThera Medical
Agreement with
Fresenius Medical
Care
Partnership - Aug 2022
▪ ExThera Medical and Fresenius Medical Care, the world’s leading
provider of products and services for individuals with renal
diseases, announced the expanded distribution of ExThera’s
Seraph® 100 Microbind® Affinity Blood Filter in Mexico. In 2021,
ExThera Medical and Fresenius Medical Care partnered to
distribute
Latest Deals - Mergers and Acquisitions
Illustrative

40
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.1 JNC International (continued)
Revenues ($Bn), 2020-2030
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

41
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative

42
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

43
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

44
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario - Nigeria

46
5.1 Reimbursement Regulation by Nigerian Government
National Health Insurance Scheme (NHIS):
▪ NHIS is a government agency responsible for implementing health insurance programs in Nigeria
▪ It offers various healthcare packages to different segments of the population, including formal sector employees, informal sector
participants, and vulnerable groups
▪ Specific reimbursement policies for dialysis treatment are typically included in the benefit packages provided by the NHIS
Benefit Packages:
▪ NHIS offers different benefit packages with varying levels of coverage. Some of these benefit packages may include coverage for
dialysis treatment, including the cost of dialysis sessions, medications, laboratory tests, and related services
▪ Coverage and reimbursement details can depend on the specific package and the contributions made by the enrollee
Enrollee Contributions:
▪ Under the NHIS, enrollees are required to make regular contributions towards their health insurance coverage
▪ These contributions vary depending on the category of enrollment (e.g., formal sector, informal sector, vulnerable group)
▪ Reimbursement for dialysis treatment may be subject to the payment of appropriate premiums and compliance with NHIS guidelines
The Nigerian government, through the National Health Insurance Scheme (NHIS), provides health insurance coverage to eligible
individuals. While the NHIS aims to improve access to healthcare services, including dialysis treatment, the specific reimbursement
policies for dialysis treatment may vary. Here are some key points regarding dialysis treatment reimbursement by the government in
Nigeria

47
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
▪ Public insurance in Nigeria is primarily provided through NHS aims to provide
affordable and accessible healthcare services to eligible individuals, including
coverage for dialysis treatment, through various benefit packages
 Private insurance plans may offer a range of coverage options, including dialysis
treatment, but the coverage and reimbursement policies can vary depending on the
specific plan and insurance provider.
▪ Reimbursement market trends in Nigeria indicate an increasing focus on expanding health insurance coverage and improving reimbursement processes for
healthcare services, including dialysis treatment
▪ There is a growing recognition of the importance of sustainable reimbursement models to ensure equitable access to quality healthcare and incentivize healthcare
providers to deliver efficient and effective services 38.9%
37.1%
35.6%
32.5%
31.5%
XX%
XX%
XX%
XX%
XX%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
XX XX XX XX XX
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
xx% xx% xx% xx% xx% xx% xx% GDP Growth (yoy)
xx% xx% xx% xx% xx% NA NA HC Spend Growth (yoy)
Illustrative

48
5.2 Reimbursement process for dialysis treatment in Nigeria
Enrollee
Registration
▪ Eligible
individuals need
to enroll in the
NHIS or the
relevant
government
health insurance
program
▪ This involves
completing the
necessary
registration
forms, providing
required
documentation,
and paying the
appropriate
premiums or
contributions
Selection of
Healthcare
Provider
▪ Enrollees can
choose a
healthcare
provider, such
as a dialysis
center or
hospital, that is
accredited and
recognized by
the NHIS
▪ It's important to
select a provider
that offers
dialysis services
and participates
in the NHIS
reimbursement
program
Treatment
Authorization:
▪ Before initiating
dialysis
treatment, the
healthcare
provider submits
a treatment
authorization
request to the
NHIS
▪ This request
includes relevant
medical
information,
prescribed
treatment plan,
and estimated
costs
Treatment
Delivery
▪ Once the
treatment
authorization is
approved by the
NHIS, the
dialysis
treatment is
initiated
according to the
prescribed plan
▪ NHIS typically
covers a certain
number of
dialysis sessions
per month,
depending on
the specific
benefit package
and policy
Claim
Submission
▪ Healthcare
provider submits
claims for
reimbursement
to the NHIS on
behalf of the
enrolled patient
▪ Claims include
details of the
provided
services,
treatment dates,
medications
used, and any
additional
necessary
documentation
Claims Review &
Reimbursement
▪ NHIS reviews
the submitted
claims to ensure
they comply with
the
reimbursement
guidelines and
policies
▪ Claims are
evaluated for
accuracy,
appropriateness
of services, and
adherence to
treatment
protocols
Patient Co-
Payment
▪ Patients is
responsible for
co-payments or
out-of-pocket
expenses that
are not covered
by the health
insurance
program
▪ These costs can
include
deductibles,
non-covered
services, or
additional
charges beyond
the coverage
limits

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Categoryname and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Categoryname
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Nigeria
and Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Nigeria, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Nigeria, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Nigeria Dialysis Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Nigeria Dialysis Market Analysis Sample Report

Similar to Nigeria Dialysis Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Nigeria Dialysis Market Analysis Sample Report